Jim Simons’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Buy
133,612
+24,523
+22% +$254K ﹤0.01% 2251
2025
Q4
$1.29M Buy
109,089
+8,300
+8% +$71.7K ﹤0.01% 2136
2025
Q3
$809K Buy
100,789
+29,969
+42% +$209K ﹤0.01% 2588
2025
Q2
$567K Buy
70,820
+306
+0.4% +$2.24K ﹤0.01% 2771
2025
Q1
$498K Buy
70,514
+1,440
+2% +$15.6K ﹤0.01% 2747
2024
Q4
$783K Sell
69,074
-568
-0.8% -$7.4K ﹤0.01% 2619
2024
Q3
$975K Buy
69,642
+13,363
+24% +$213K ﹤0.01% 2460
2024
Q2
$894K Sell
56,279
-3,997
-7% -$97.8K ﹤0.01% 2382
2024
Q1
$1.63M Sell
60,276
-892
-1% -$21.5K ﹤0.01% 2163
2023
Q4
$1.24M Buy
61,168
+11,448
+23% +$158K ﹤0.01% 2266
2023
Q3
$654K Buy
49,720
+765
+2% +$12.6K ﹤0.01% 2584
2023
Q2
$922K Buy
48,955
+710
+1% +$14K ﹤0.01% 2515
2023
Q1
$924K Sell
48,245
-11,313
-19% -$307K ﹤0.01% 2531
2022
Q4
$1.64M Sell
59,558
-3,512
-6% -$88.6K ﹤0.01% 2199
2022
Q3
$1.58M Buy
63,070
+11,790
+23% +$465K ﹤0.01% 2191
2022
Q2
$2.42M Buy
51,280
+12,485
+32% +$583K ﹤0.01% 2049
2022
Q1
$2.4M Buy
38,795
+15,015
+63% +$1.24M ﹤0.01% 2094
2021
Q4
$3.02M Buy
23,780
+17,120
+257% +$2.8M ﹤0.01% 1844
2021
Q3
$1.33M Buy
6,660
+3,445
+107% +$821K ﹤0.01% 2389
2021
Q2
$851K Buy
+3,215
New +$995K ﹤0.01% 2743
2020
Q4
Sell
-1,260
Closed -$330K 3636
2020
Q3
$330K Buy
+1,260
New +$434K ﹤0.01% 2960

Other funds holding PASG

Jim Simons's PASG Position: Q1 2026 in Review

Jim Simons increased its Passage Bio (PASG) stake by 22% in Q1 2026, buying an estimated $254K and bringing the position to 133,612 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Jim Simons first reported a position in PASG in Q3 2020 and has held it in 21 quarters since. The position peaked at $3.02M in Q4 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Jim Simons held 133,612 shares of Passage Bio worth $1.05M as of Q1 2026.
  • Jim Simons bought 24,523 Passage Bio shares in Q1 2026, an estimated $254K.
  • Passage Bio made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2251 holding.
  • Jim Simons first reported a position in Passage Bio in Q3 2020 and has held it in 21 quarters since.
  • Jim Simons's Passage Bio position peaked at $3.02M in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.